BIOMAT Database Logo BIOMAT Database Logo

Insulin-sensitive adenosine 3',5'-cyclic monophosphate phosphodiesterase of hepatocyte plasma membrane. 1977

E Tria, and S Scapin, and C Cocco, and P Luly

Adenosine 3',5'-cyclic monophosphate phosphodiesterase (EC 3.1.4.17) has been investigated in rat liver as to its insulin sensitivity. Hormone action has been assayed in vitro on a liver homogenate purified by DEAE-cellulose column chromatography, on isolated hepatocytes, on isolated plasma membranes. The DEAE-cellulose chromatography purified homogenate showed no sensitivity to insulin, whereas isolated hepatocytes incubated in presence of insulin showed increased phosphodiesterase activity in a plasma membrane-containing fraction. The plasma membrane-bound enzyme, which shows both high and low affinity components, was significantly stimulated after hormonal treatment; this effect being dependent on a V increase of the low Km form.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D010727 Phosphoric Diester Hydrolases A class of enzymes that catalyze the hydrolysis of one of the two ester bonds in a phosphodiester compound. EC 3.1.4. Phosphodiesterase,Phosphodiesterases,Hydrolases, Phosphoric Diester
D011384 Proinsulin A pancreatic polypeptide of about 110 amino acids, depending on the species, that is the precursor of insulin. Proinsulin, produced by the PANCREATIC BETA CELLS, is comprised sequentially of the N-terminal B-chain, the proteolytically removable connecting C-peptide, and the C-terminal A-chain. It also contains three disulfide bonds, two between A-chain and B-chain. After cleavage at two locations, insulin and C-peptide are the secreted products. Intact proinsulin with low bioactivity also is secreted in small amounts.
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002848 Chromatography, DEAE-Cellulose A type of ion exchange chromatography using diethylaminoethyl cellulose (DEAE-CELLULOSE) as a positively charged resin. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) DEAE-Cellulose Chromatography,Chromatography, DEAE Cellulose,DEAE Cellulose Chromatography
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations

Related Publications

E Tria, and S Scapin, and C Cocco, and P Luly
Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase.
December 1970, The Biochemical journal,
E Tria, and S Scapin, and C Cocco, and P Luly
3':5'-cyclic adenosine monophosphate phosphodiesterase: negative cooperativity.
July 1972, Proceedings of the National Academy of Sciences of the United States of America,
E Tria, and S Scapin, and C Cocco, and P Luly
Cyclic 3',5'-adenosine monophosphate phosphodiesterase of Escherichia coli.
November 1973, Journal of bacteriology,
E Tria, and S Scapin, and C Cocco, and P Luly
The role of adenosine 3':5'-cyclic monophosphate in the regulation of insulin release. Properties of islet-cell adenosine 3':5'-cyclic monophosphate phosphodiesterase.
October 1972, The Biochemical journal,
E Tria, and S Scapin, and C Cocco, and P Luly
An effect of insulin on adipose-tissue adenosine 3':5'-cyclic monophosphate phosphodiesterase.
November 1970, The Biochemical journal,
E Tria, and S Scapin, and C Cocco, and P Luly
Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in malignant and cyclic adenosine 3':5'-monophosphate-induced "differentiated" neuroblastoma cells.
January 1975, Cancer research,
E Tria, and S Scapin, and C Cocco, and P Luly
Acylpeptides, the inhibitors of cyclic adenosine 3',5'-monophosphate phosphodiesterase.
February 1983, The Journal of antibiotics,
E Tria, and S Scapin, and C Cocco, and P Luly
Reticulol, an inhibitor of cyclic adenosine 3', 5'-monophosphate phosphodiesterase.
July 1975, The Journal of antibiotics,
E Tria, and S Scapin, and C Cocco, and P Luly
Cyclic 3', 5'-adenosine monophosphate phosphodiesterase mutants of Salmonella typhimurium.
June 1975, Journal of bacteriology,
E Tria, and S Scapin, and C Cocco, and P Luly
Effect of reductones on cyclic 3', 5'-adenosine monophosphate phosphodiesterase.
January 1985, Acta vitaminologica et enzymologica,
Copied contents to your clipboard!